| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/26/2013 | US20130345148 Prevention and treatment of ocular side effects with a cyclosporin |
| 12/26/2013 | US20130345147 Prevention and treatment of ocular side effects with a cyclosporin |
| 12/26/2013 | US20130345146 Near-infrared electromagnetic modification of cellular steady-state membrane potentials |
| 12/26/2013 | US20130345145 Atip3 and biologically active fragments thereof for use in the treatment of cancer |
| 12/26/2013 | US20130345140 Basement Membrane Compositions and Applications Thereof |
| 12/26/2013 | US20130345139 Composition for nutrition purposes |
| 12/26/2013 | US20130345137 Method of inhibiting angiogenesis and food/beverage composition for angiogenesis inhibition |
| 12/26/2013 | US20130345135 Inhibition of mypb-c binding to myosin as a treatment for heart failure |
| 12/26/2013 | US20130345134 Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid |
| 12/26/2013 | US20130345133 Adiponectin for Treating Pulmonary Disease |
| 12/26/2013 | US20130345132 Use of hgh for the treatment of small for gestational age infants under two years of age |
| 12/26/2013 | US20130345131 Method for Achieving Desired Glial Growth Factor 2 Plasma Levels |
| 12/26/2013 | US20130345130 Pharmaceutical composition for preventing or treating heart failure and method for screening agent for preventing or treating heart failure |
| 12/26/2013 | US20130345124 Methods and kits for preventing hypoglycemia |
| 12/26/2013 | US20130345123 Substituted adipic acid amides and uses thereof |
| 12/26/2013 | US20130345116 Composition Containing Trail for Prevention or Treatment of Metabolic Diseases |
| 12/26/2013 | US20130345115 Nuclear penetrating h4 tail peptides for the treatment of diseases mediated by impaired or loss of p53 function |
| 12/26/2013 | US20130345114 Agent for Treating Allergic or Hypersensitivity Condition |
| 12/26/2013 | US20130345113 Method of Use of Activated Functional Proteins to Improve Animal Health |
| 12/26/2013 | US20130344179 Anti-fatigue composition |
| 12/26/2013 | US20130344173 Modulating disease through genetic engineering of plants |
| 12/26/2013 | US20130344166 Topical mixture and method for dermal application to remove excess iron and other heavy metals from cellular tissue |
| 12/26/2013 | US20130344153 Method for reducing incidence or rate of development of skin cancers and related conditions |
| 12/26/2013 | US20130344145 Orally administered pharmaceutical composition for the treatment of irritable bowel syndrome, comprising an intestinal motility modifier, an agent that prevents gas retention, and digestive enzymes, and preparation method thereof |
| 12/26/2013 | US20130344137 Functional foods comprising diamine oxidase and uses thereof |
| 12/26/2013 | US20130344136 Composition comprising diamine oxidase for the prevention of hangover symptoms |
| 12/26/2013 | US20130344130 Smart, Self-Decontaminating Polymer and Method for Inhibiting The Growth Of A Bacteria and Fungus |
| 12/26/2013 | US20130344119 Method for inducing in vivo migration of stem cell |
| 12/26/2013 | US20130344102 Formulation |
| 12/26/2013 | US20130344082 Methods of treating or preventing periodontitis and diseases associated with periodontitis |
| 12/26/2013 | US20130344056 Keratin biomaterials for treatment of ischemia |
| 12/26/2013 | US20130344053 Methods of Modifying Insulin Signaling Using Biliverdin Reductase (BVR) and BVR Derived Peptides |
| 12/26/2013 | US20130344051 Compostion of matter for treating or preventing various types of cancer and neoplastic diseases in a mammal |
| 12/26/2013 | US20130344049 Methods for treatment of ocular diseases |
| 12/26/2013 | US20130344048 Method of reducing insulin resistance by administering a Hyaluronan-degrading enzyme |
| 12/26/2013 | US20130344047 Methods And Composition For Treating Heart Failure And Ischemia |
| 12/26/2013 | US20130344040 Process for the preparation of a composition of genetically modified hematopoietic progenitor cells |
| 12/26/2013 | US20130344032 Method of Treating Anemia Caused By Ribavirin Treatment of Hepatitis C Using Erythropoietin Alpha |
| 12/26/2013 | US20130344030 Macrocyclic inhibitors of flaviviridae viruses |
| 12/26/2013 | US20130344029 Macrocyclic inhibitors of flaviviridae viruses |
| 12/26/2013 | US20130344028 1'-substituted carba-nucleoside analogs for antiviral treatment |
| 12/26/2013 | US20130344027 Multi-functional polymeric materials and their uses |
| 12/26/2013 | US20130344026 Dimeric Smac Mimetics |
| 12/26/2013 | US20130344025 Method for the administration of ligands, agonists of ligands of the tnf family with reduced toxicity |
| 12/26/2013 | US20130344024 Co-Therapy for Diabetic Conditions |
| 12/26/2013 | US20130343996 Graphite-coated magnetic nanoparticles |
| 12/25/2013 | EP2676680A1 Use of hydrophobin polypeptides as penetration enhancers |
| 12/25/2013 | EP2676675A2 Composition containing inducer of sirt1 expression for preventing or treating sepsis or septic shock |
| 12/25/2013 | EP2676674A1 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| 12/25/2013 | EP2676673A2 Glucagon/glp-1 receptor co-agonists |
| 12/25/2013 | EP2676659A1 HDL comprising a therapeutic agent and use in therapy |
| 12/25/2013 | EP2676142A1 Methods and compositions relating to coagulation assays |
| 12/25/2013 | EP2675895A2 Molecular switch for neuronal outgrowth |
| 12/25/2013 | EP2675824A2 Copolymer-1, process for preparation and analytical methods thereof |
| 12/25/2013 | EP2675814A1 Haprolid and derivatives thereof as inhibitors of hcv |
| 12/25/2013 | EP2675478A2 Compositions and methods for the therapy and diagnosis of influenza |
| 12/25/2013 | EP2675472A1 Methods for treating lysosomal acid lipase deficiency |
| 12/25/2013 | EP2675471A1 Hsa-related compositions and methods of use |
| 12/25/2013 | EP2675470A1 Long-acting il-1 receptor antagonists |
| 12/25/2013 | EP2675469A2 Compositions, devices and methods of use thereof for the treatment of cancers |
| 12/25/2013 | EP2675468A1 Method for treating breast cancer by decreasing the expression of adenine nucleotide translocator 2 mrna |
| 12/25/2013 | EP2675467A1 Use of mdl-1 antagonists to treat spondylarthropathy |
| 12/25/2013 | EP2337573B1 Whey for use in treating lymphocytopenia |
| 12/25/2013 | EP2269622B1 CpG oligonucleotides used for enhancing steroid activity in a steroid dependent patient |
| 12/25/2013 | EP2198890B1 Combinatorial libraries of monomer domains |
| 12/25/2013 | EP2145957B1 Compositions for enhancing delivery of double-stranded RNA to regulate gene expression in mammalian cells |
| 12/25/2013 | EP2056865B1 Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health |
| 12/25/2013 | EP2016952B1 A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
| 12/25/2013 | EP1993590B1 Compostions and methods for administering gdnf ligand family proteins |
| 12/25/2013 | CN1968710B Stable peptide mimetic of HIV gp41 fusion intermediate |
| 12/25/2013 | CN103476933A Antagonists of the interleukin-1 receptor |
| 12/25/2013 | CN103476800A Fusion protein |
| 12/25/2013 | CN103476793A Subcutaneously administered anti-IL-6 receptor antibody |
| 12/25/2013 | CN103476792A Human lactoferrin derived peptides and use thereof |
| 12/25/2013 | CN103476791A Novel WNT compositions and therapeutic uses of such compositions |
| 12/25/2013 | CN103476786A Method for producing injectable formulations of blood-derived protein materials, and materials obtained using said method |
| 12/25/2013 | CN103476423A Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome |
| 12/25/2013 | CN103476422A Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain |
| 12/25/2013 | CN103476399A Drug delivery particles and method for producing same |
| 12/25/2013 | CN103476396A Suspension type topical formulations comprising cyclic depsipeptide |
| 12/25/2013 | CN103468704A Peptidoglycan binding protein BjApextrin2, as well as gene, production method and application thereof |
| 12/25/2013 | CN103468673A Preparation method and applications of antibacterial peptide |
| 12/25/2013 | CN103467604A Sleep-inducing peptide fusion protein and its application |
| 12/25/2013 | CN103467594A Insulin modifier and preparation method and application thereof |
| 12/25/2013 | CN103467592A Interferon alpha mutant and polyethylene glycol derivate thereof |
| 12/25/2013 | CN103467590A Biological couplet, purine compounds for preparing biological couplet, synthetic method for preparing biological couplet, pharmaceutical preparation prepared from biological couplet and application of biological couplet in immune adjustment |
| 12/25/2013 | CN103467588A Stabilized alpha helical peptides and uses thereof |
| 12/25/2013 | CN103467583A Variants of group 1 allergens of poaceae with reduced allergenicity and a maintained t-cell reactivity |
| 12/25/2013 | CN103467580A Preparation method and application of artificial antimicrobial peptide MA-D4 |
| 12/25/2013 | CN103467579A Cation amphipathic self-assembly nano antibacterial peptide and application thereof |
| 12/25/2013 | CN103467578A Short peptide, cooper loading nanometer biological material and application of cooper loading nanometer biological material in cerebral infarction treatment drug preparation |
| 12/25/2013 | CN103467577A Short-peptide, copper-loaded nanometer biomaterial and application to preparation of medicaments for treating lower limb ischemic diseases |
| 12/25/2013 | CN103467570A Transmembrane polypeptide with analgesic effect |
| 12/25/2013 | CN103467569A Short peptide for bacterium resisting, itching relieving, inflammation diminishing, swelling eliminating and scar removing, and its application |
| 12/25/2013 | CN103467568A Sepia esculenta protein antioxidant peptide, and preparation method and use thereof |
| 12/25/2013 | CN103467565A Boronate ester compounds and pharmaceutical compositions thereof |
| 12/25/2013 | CN103467502A Phenylboronic acid organogel compound |
| 12/25/2013 | CN103463646A Application of E2F1 protein in preparation of medicine for diagnosing and treating osteosarcoma |
| 12/25/2013 | CN103463629A Preparation method and application of premature ovarian failure non-human mammal model |
| 12/25/2013 | CN103463628A Drug composition for treating or preventing senile dementia, and preparation thereof |